Wang et al. [10] studied the relationships between EGFR rs730437 and rs1468727 polymorphisms and glioma risk, and Andersson et al.’s study [22] explored the relationships between EGFR rs730437, rs1468727, rs9642393, rs11506105, rs845552, rs3752651 polymorphisms and glioma risk. This evidence concerns the gene EGFR and central nervous system cancer.